BK 218
| Code | Size | Price |
|---|
| TAR-T30481-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
BK 218 is a novel cephalosporin, which is active against streptococcus pneumoniae, Haemophilus influenza, and Moraxella catarrase, but has a higher MIC against penicillin-resistant strains. Bk-218 has dual administration routes and the activity spectrum most similar to the second generation cephalosporins.
CAS:
110008-56-5
Formula:
C15H13ClN7NaO5S2
Molecular Weight:
493.87
Purity:
0.98
SMILES:
[Na+].Cn1nnnc1SCC1=C(N2C(SC1)C(NC(=O)Cc1cc(Cl)no1)C2=O)C([O-])=O
References
1. Szab? I, Barab?s J, Tar A, Kiss L, Filep M, Schmidt T, Marossy K, T?th-Martinez B, Barab?s G, Hern?di F. In vitro investigation of BK-218, a new oral and parenteral cephalosporin. Antimicrob Agents Chemother. 1990 Feb;34(2):349-54. PubMed PMID: 2109582; PubMed Central PMCID: PMC171585.
2. Johnson DM, Jones RN. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218. Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):181-8. PubMed PMID: 1396735.
3. Jones RN, Erwin ME, Barrett MS. Antimicrobial activity of three investigational oral cephalosporins (BK-218, cefdinir, and RU29246) against Legionella. Diagn Microbiol Infect Dis. 1991 Nov-Dec;14(6):519-21. PubMed PMID: 1802542.